Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with Platelet Factor 4

Sallard, Erwan, Pembaur, Daniel, Ciancaglini, Matias, Manov-Bouard, Lucie, Weklak, Denice, Hamdan, Firas, Chan, Chun Kit, Jönsson, Franziska, Chabot, Elise, Musielak, Carmen, Scurti, Elena, Feola, Sara, Schellhorn, Sebastian, Beaude, Nissai, Schröer, Katrin, Sarkar, Daipayan, Koukou, Georgia, Wang, Xiaoyan, Schmidt, Natascha, Bayer, Wibke, Aydin, Malik, Kemp, Vera, Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761, Grimm, Dirk, Viitala, Tapani, Cerullo, Vincenzo, Singharoy, Abhishek, Baker, Alexander T., Zhang, Wenli, Pinschewer, Daniel, Kreppel, Florian and Ehrhardt, Anja 2025. Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with Platelet Factor 4. iScience , 114329. 10.1016/j.isci.2025.114329

Full text not available from this repository.

Abstract

The adenoviral vector-based AstraZeneca and Janssen COVID-19 vaccines have been associated with rare cases of thrombosis, believed to be triggered among other factors by vector binding to the blood protein platelet factor 4 (PF4). To identify vectors with lower thrombosis risk, we screened 50 natural and hexon-modified adenoviruses (Ad). Unlike the applied COVID-19 vaccines and most tested vectors, Ad34 and Ad80 as well as Ad5 vectors with deleted or chemically shielded hexon hyper-variable region 1 (HVR1), did not bind to PF4. Furthermore, interactions with PF4 substantially modified Ad5 infectivity in various immortalized and primary cells, suggesting that PF4 may influence existing vector tropism. Finally, HVR1-deleted Ad5 and Ad34 vectors expressing SARS-CoV-2 spike S1 domain were tested as vaccine candidates in mice and induced robust cellular immune responses. Therefore, the identified PF4 non-binding vectors may represent safe and efficient candidates for clinical applications.

Item Type: Article
Date Type: Published Online
Status: In Press
Schools: Schools > Medicine
Publisher: Cell Press
ISSN: 2589-0042
Funders: Cancer Research UK
Date of Acceptance: 1 December 2025
Last Modified: 09 Dec 2025 16:30
URI: https://orca.cardiff.ac.uk/id/eprint/182957

Actions (repository staff only)

Edit Item Edit Item